Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - dexamethasone sodium phosphate - solution for injection - dexamethasone

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - dexamethasone sodium phosphate - solution for injection - dexamethasone

United States - English - NLM (National Library of Medicine)

direct rx - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - dexamethasone 1.5 mg - allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, seasonal or perennial allergic rhinitis and serum sickness. dermatologic diseases bullous dermatitis herpetiformis, exfoliative erythroderma, mycisis fungoides, pemphigus, and severe erythema multiforme (stevens-johnson syndrome). endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; in infancy mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, and nonsuppurative thyroiditis. gastrointestinal diseases to tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis. hematologic disorders acquired (autoimmune) hemolytic anemia, congen

Ireland - English - HPRA (Health Products Regulatory Authority)

alissa healthcare research limited - dexamethasone sodium phosphate - eye drops, solution - 1.0 milligram(s)/millilitre - corticosteroids, plain; dexamethasone - corticosteroids, plain - for treatment of non-infectious inflammatory conditions affecting the anterior segment of the eye

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - dexamethasone sodium phosphate - solution for injection - 4 milligram(s)/millilitre - glucocorticoids; dexamethasone

Ireland - English - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd - dexamethasone sodium phosphate - solution for injection/infusion - 4 milligram(s)/millilitre - glucocorticoids; dexamethasone

Ireland - English - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - dexamethasone sodium phosphate - solution for injection/infusion - 4 milligram(s)/millilitre - glucocorticoids; dexamethasone - glucocorticoids - it e can be used for all forms of general and local glucocorticoid injection therapy and all acute conditions in which intravenous glucocorticoids may be life-saving.

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - dexamethasone sodium phosphate - solution for injection/infusion - 4/1 milligram(s)/millilitre - glucocorticoids; dexamethasone

Israel - English - Ministry of Health

pharmalogic ltd - dexamethasone phosphate (as sodium) - solution for injection / infusion - dexamethasone phosphate (as sodium) 4 mg / 1 ml - dexamethasone - dexamethasone panpharma is indicated in the treatment ofendocrine diseases such as nonsuppurative thyroiditis, hypercalcaemia associated with cancer and congenital adrenal hyperplasia.allergy: severe or disabling allergic conditions resistant to conventional treatments, as in: bronchial asthma, contact or atopical dermatitis, seasonal or perennial allergic rhinitis, hypersensitivity reactions to drugs. ophtalmic: serious inflammatory and allergic processes, acute and chronic, affecting the eyes, such as: iritis and iridocyclitis, chorioretinitis, choroiditis and diffuse posterior uveitis, optical neuritis, allergic conjunctivitis, allergic marginal corneal ulcers. inflammatory bowel dis.: systemic treatment in exacerbations of ulcerative colitis and regional enteritis. dermatological diseases (pemphigus, stevens johnson syndrome, exfoliative dermatitis, severe psoriasis and mycosis fungoides) respiratory diseases (symptomatic sarcoidosis, berylliosis, loeffler's syndrome) haematological: acquired )autoimmune( haemolytic anaemia, idiopathic thrombocytopenic purpura in adult, pure red cell aplasia nephrotic syndrome of the idiopathic type or that due to lupus erythematosus cerebral oedema caused by brain tumor, neurosurgery, brain abscess, bacterial meningitis collagen diseases: active rheumatoid arthritis with severe progressive course, fast destructive remitting forms and / or extra-articular manifestations, juvenile idiopathic arthritis with severe systemic-onset form (still's disease) or locally with no control, rheumatic fever with carditis, dermatomyositis, polymyositis, sle, temporal arteritis. infectious diseases: bacterial meningitis – adjunct to antibiotics in suspected pneumococcal meningitis and tb meningitis. severe infectious diseases with toxic states (eg tuberculosis, typhoid, brucellosis;. only with simultaneous anti-infective therapy) fetal lung maturation chemotherapy – associated nausea and vomiting multiple myeloma – part of chemotherapy protocols (eg vad) prevention and treatment of acute mountain sickness/hace

United States - English - NLM (National Library of Medicine)

cardinal health - dexamethasone sodium phosphate (unii: ai9376y64p) (dexamethasone - unii:7s5i7g3jql) - by intravenous or intramuscular injection when oral therapy is not feasible: 1. endocrine disorders      primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids      where applicable; in infancy, mineralocorticoid supplementation is of particular importance).      acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogs      are used).      preoperatively, and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful.      shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is suspected.      congenital adrenal hyperplasia      nonsuppurative thyroiditis      hypercalcemia associated with cancer 2. rheumatic disorders      as adjunctive therapy for short-term administration (t